Paper Details

  1. Home
  2. Paper Details

A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss.

Author: DeviGayatri, KhosrowshahiLynn, LaaksoUlla K, MassimiSteve, SchultzSarah

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Women approaching and going through menopause often report memory problems more than women who are not yet menopausal. While the link between menopause and cognitive decline is debated, recent studies on hormone therapy have led many women and doctors to seek non-hormonal treatments for menopausal symptoms, including memory issues.
Paper Details　
Original Abstract of the Article :
Perimenopausal and menopausal women are more likely to complain of memory loss than are premenopausal women, although the association between menopause and cognitive loss remains controversial. Recently published studies on the risks of hormone therapy have left many women and their physicians seeki...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s1550-8579(07)80064-7

データ提供：米国国立医学図書館（NLM）

Donepezil for Menopause-Related Cognitive Loss: A Double-Blind Trial

This study investigates the potential benefits of donepezil, a medication used to treat Alzheimer's disease, for menopause-related cognitive loss. The authors conducted a double-blind, placebo-controlled trial to assess the efficacy of donepezil in improving cognitive function in perimenopausal and menopausal women. The results suggest that donepezil may offer a potential non-hormonal treatment option for cognitive decline associated with menopause.

Navigating the Menopause Desert: Finding Cognitive Relief

Menopause, a natural transition in a woman's life, can bring a variety of challenges, including cognitive decline. This study explores a potential oasis for relief, investigating the use of donepezil for menopause-related cognitive loss. While the results are promising, further research is needed to fully understand the benefits and risks of this approach. Just as a camel adapts to the shifting sands of the desert, women navigating menopause may need to explore different strategies to maintain cognitive function and overall well-being.

Living with Menopause: A Journey of Self-Care and Empowerment

Menopause is a unique journey for every woman. It's essential to listen to your body and seek support from healthcare professionals. If you are experiencing cognitive decline, don't hesitate to discuss your concerns with your doctor. Remember, like the desert, which offers both challenges and opportunities for growth, menopause is a time for self-discovery and resilience. With the right support, you can embrace this transition with confidence and grace.

Dr. Camel's Conclusion

This study offers a glimmer of hope in the desert of menopause-related cognitive loss. While donepezil shows promise as a potential non-hormonal treatment, further research is needed to confirm its efficacy and safety. It's important to remember that every woman's journey through menopause is unique, and there is no one-size-fits-all approach. Like a camel traversing a vast desert landscape, finding the right path requires patience, resilience, and self-care. With the right support, you can navigate this transition with strength and confidence.

Date :
  1. Date Completed 2008-03-20
  2. Date Revised 2020-09-28
Further Info :

Pubmed ID

18215726

DOI: Digital Object Identifier

10.1016/s1550-8579(07)80064-7

Related Literature

Article Analysis
・Effective treatment of menopause
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.